South Sudan vs Sri Lanka: Prevalence rate of hypertension in women aged 30-79
South Sudan
36
in 2019
Sri Lanka
36.5
in 2019
South Sudan rank
114th
Sri Lanka rank
111th
Prevalence rate of hypertension in women aged 30-79 over time
- South Sudan
- Sri Lanka
How they compare
Sri Lanka currently reports 36.5 against 36 in South Sudan, a difference of 0.5.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was South Sudan ahead.
South Sudan ranks 114th and Sri Lanka ranks 111th of 195 countries.
South Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Sudan | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 34.99 | 32.09 | 2.9 | South Sudan |
| 2000s | 36.83 | 32.33 | 4.5 | South Sudan |
| 2010s | 36.95 | 35 | 1.95 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, South Sudan or Sri Lanka?
- Sri Lanka, at 36.5 against 36 in South Sudan as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between South Sudan and Sri Lanka?
- 0.5, with Sri Lanka ahead.
- How many years of comparable data are there for South Sudan and Sri Lanka?
- 30 years are reported by both, from 1990 to 2019.
- How do South Sudan and Sri Lanka rank globally for prevalence rate of hypertension in women aged 30-79?
- South Sudan ranks 114th and Sri Lanka ranks 111th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.